Can hand shaking in a 14-year-old male on fluoxetine 40 mg daily, Strattera (atomoxetine) 100 mg daily, buspirone 15 mg twice daily, and trazodone 100 mg at bedtime be caused by these medications, or should he be referred to a physician?

Yes, Multiple Medications in This Regimen Can Cause Hand Shaking

Several of this patient's medications—particularly fluoxetine, atomoxetine (Strattera), and buspirone—are known to cause tremor, and the combination increases this risk substantially. However, you should still evaluate for other causes and consider medical referral depending on tremor characteristics and severity.

Medication-Induced Tremor: The Primary Culprits

Fluoxetine (SSRI)

Fluoxetine commonly causes tremor as a recognized adverse effect. The FDA label specifically warns that fluoxetine may impair motor skills and lists tremor among typical side effects 1. In a cohort study of 21 patients, fluoxetine-induced tremor appeared at a mean dose of 25.7 mg (this patient takes 40 mg) after approximately 54 days, presenting as postural tremor at 6-12 Hz 2. Notably, tremor persisted in over half of patients even after fluoxetine discontinuation, suggesting potential for lasting effects 2.

Atomoxetine (Strattera)

The FDA label for atomoxetine warns about akathisia (psychomotor restlessness) and other movement abnormalities 3. Case reports document dyskinesias and tremors when atomoxetine is combined with other psychoactive medications, particularly those affecting dopaminergic or serotonergic systems 4. At 100 mg daily, this patient is at the higher end of dosing, which increases risk.

Buspirone

While less commonly associated with tremor than SSRIs, buspirone can contribute to tremor, particularly when combined with serotonergic agents 5.

Trazodone

Trazodone has documented associations with movement disorders, including parkinsonism and tremor 6. One case report described reversible parkinsonism after just 14 days of trazodone 100 mg, with symptom recurrence upon rechallenge 6.

Critical Drug Interaction Concerns

This patient is taking multiple serotonergic medications simultaneously (fluoxetine + buspirone + trazodone), which substantially increases the risk of serotonin syndrome. 7, 8

Warning Signs to Assess Immediately:

• Neuromuscular excitation: Tremor, clonus, hyperreflexia, muscle rigidity
• Autonomic instability: Tachycardia, hypertension, diaphoresis, fever
• Altered mental status: Agitation, confusion, restlessness

A recent case report documented serotonin syndrome from rapid titration of sertraline and trazodone, presenting with myoclonus, tremor, diaphoresis, and altered mental status 8. Another case showed worsening myoclonus from the trazodone-fluoxetine combination 9.

Clinical Evaluation Algorithm

Immediate Assessment (Can Be Done Without Referral):

1. Characterize the tremor:

   • Postural (arms extended) vs. resting vs. action/intention
   • Frequency and amplitude
   • Unilateral vs. bilateral
   • Duration and progression

2. Screen for serotonin syndrome (requires urgent medical evaluation if positive):

   • Check vital signs (fever, tachycardia, hypertension)
   • Assess for hyperreflexia, clonus (especially ankle/ocular)
   • Evaluate mental status changes
   • Look for diaphoresis, mydriasis

3. Review medication timeline:

   • When did tremor start relative to medication initiation/dose changes?
   • Any recent dose increases?

Refer to Medical Doctor If:

• Any signs of serotonin syndrome (this is a medical emergency)
• Tremor is unilateral or task-specific (suggests dystonic or other neurological cause)
• Sudden onset with distractibility/entrainment (suggests functional tremor)
• Progressive worsening despite medication adjustment
• Interferes significantly with activities of daily living
• Patient has risk factors for other causes: family history of essential tremor, signs of parkinsonism beyond tremor, thyroid symptoms

Management Recommendations

If tremor is mild-moderate and serotonin syndrome is ruled out:

1. Consider dose reduction of fluoxetine first (highest tremor risk at this dose) 2
2. Evaluate necessity of polypharmacy: Does this patient need all four psychotropic medications? 10
3. Monitor closely for 2-4 weeks after any medication adjustment
4. Do not abruptly discontinue SSRIs or trazodone due to discontinuation syndrome risk 7, 1

The combination of an SSRI, SNRI-like agent (atomoxetine), buspirone, and trazodone represents significant polypharmacy with overlapping serotonergic effects. 7 Guidelines emphasize that medication combinations require clear rationale and careful monitoring 10.

Common Pitfalls to Avoid

• Don't assume tremor is benign without ruling out serotonin syndrome—this can be life-threatening
• Don't abruptly stop medications—taper gradually to avoid withdrawal symptoms 11, 1
• Don't add another medication to treat the tremor without first addressing the underlying polypharmacy
• Don't overlook that tremor may persist even after stopping the offending agent, particularly with fluoxetine 2